ABILITY Neurotech Announces First-In-Human Testing for Novel Brain-Computer Interface Technology

Summary

ABILITY Neurotech completed its first-in-human procedure for its implantable BCI technology during intra-operative recordings in brain-tumor patients at TUM University Hospital Rechts der Isar in Munich. The study validates neural signal acquisition in a live surgical setting and prepares for planned chronic first-in-human implants later in 2026.